Healthcare provider perspectives on COVID-19 vaccination for children in India

• Published in: BMJ paediatrics open 2023-11, Vol.7 (1), p.e002165
• Main Authors: Mehta, Kayur, Kaur, Amarpreet, Banerjee, Preetika, Gupta, Piyush, Thacker, Naveen, Saxena, Vineet, Shet, Anita
• Format: Article
• Language: English
• Subjects: Caregivers; COVID-19; COVID-19 vaccines; Demographics; Disease transmission; Hospitals; Immunisation; Immunization; Maternal & child health; Mortality; Pandemics; Pediatrics; Perceptions; Polls & surveys; Public health; Severe acute respiratory syndrome coronavirus 2
• ISSN: 2399-9772; 2399-9772
• DOI: 10.1136/bmjpo-2023-002165

BackgroundThe rapid development and deployment of effective COVID-19 vaccines have been critical to halt the spread of the pandemic. India started vaccinating children in early 2022, however, vaccine uptake has been suboptimal.MethodsBetween September and November 2022, we conducted an online survey that was disseminated to eligible participants via email, text messages and social media platforms across India. The survey aimed to gather the perspectives of Indian healthcare providers regarding key factors related to the rollout of paediatric COVID-19 vaccines. Descriptive statistics were used to analyse participant demographics and responses on knowledge about paediatric COVID-19 vaccines, perceived risks and benefits, and vaccine rollout strategies.ResultsThe survey yielded 805 respondents from 23 Indian states; 63.5% were men, 97.3% were paediatricians, median age was 44 years (IQR 25–81). Eighty-one per cent and 65.2% respondents had heard about the most common paediatric COVID-19 vaccines in India, Covaxin and Corbevax, but only 52.9%, 53.7% and 62.1% felt adequately informed about their safety, efficacy and vaccination schedules, respectively. Thirty per cent of respondents were unaware of vaccination guidelines. Eighty-five per cent of respondents felt that vaccines would reduce the incidence of severe disease, hospitalisation and deaths, and 60.6% felt children with comorbidities should be prioritised for vaccination. Perceived supply side barriers included lack of enforcement of guidelines (45.2%) and adverse effects following immunisation monitoring systems (37.6%), and on the demand side, parental vaccine hesitancy (64.4%). Eighty-one per cent believed that school-based vaccination strategies would be highly effective in increasing uptake.ConclusionsMost respondents were in support of the COVID-19 paediatric vaccination, although just over half did not feel adequately informed. Concerns about vaccine hesitancy among caregivers were the leading reported barrier. Targeted interventions are needed to provide adequate knowledge support to healthcare providers and evidence-based public health messaging to reduce vaccine hesitancy among caregivers.